Sintx Technologies (NASDAQ:SINT) Shares to Reverse Split on Tuesday, May 28th

Sintx Technologies, Inc. (NASDAQ:SINTFree Report) shares are going to reverse split on the morning of Tuesday, May 28th. The 1-200 reverse split was announced on Tuesday, May 28th. The number of shares owned by shareholders will be adjusted after the closing bell on Tuesday, May 28th.

Sintx Technologies Stock Performance

Sintx Technologies stock opened at $0.07 on Friday. Sintx Technologies has a fifty-two week low of $0.02 and a fifty-two week high of $1.82. The stock has a market cap of $8.29 million, a PE ratio of -0.04 and a beta of 1.39. The firm’s 50-day simple moving average is $0.06 and its 200 day simple moving average is $0.21.

Sintx Technologies (NASDAQ:SINTGet Free Report) last released its quarterly earnings results on Wednesday, March 27th. The company reported ($0.09) earnings per share for the quarter. Sintx Technologies had a negative return on equity of 81.96% and a negative net margin of 318.99%. The firm had revenue of $0.90 million for the quarter.

Analyst Upgrades and Downgrades

Separately, Maxim Group reaffirmed a “hold” rating on shares of Sintx Technologies in a research report on Monday, February 5th.

Read Our Latest Stock Analysis on Sintx Technologies

Institutional Trading of Sintx Technologies

A hedge fund recently bought a new stake in Sintx Technologies stock. Anson Funds Management LP acquired a new position in Sintx Technologies, Inc. (NASDAQ:SINTFree Report) during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund acquired 959,297 shares of the company’s stock, valued at approximately $47,000. Anson Funds Management LP owned 4.23% of Sintx Technologies as of its most recent filing with the Securities & Exchange Commission. Hedge funds and other institutional investors own 18.38% of the company’s stock.

About Sintx Technologies

(Get Free Report)

Sintx Technologies, Inc, an advanced ceramics company, engages in the research, development, and commercialization of medical devices manufactured with silicon nitride for biomedical, technical, and antipathogenic applications in the United States. It provides solid and porous silicon nitride; silicon nitrite powder; and silicon nitride coating products, as well as silicon nitride composite materials, polyetheretherketone, and polyetherketoneketone.

Featured Stories

Receive News & Ratings for Sintx Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sintx Technologies and related companies with MarketBeat.com's FREE daily email newsletter.